about
High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failureGenome-wide conserved consensus transcription factor binding motifs are hyper-methylatedRegulation of p53 tetramerization and nuclear export by ARCAkt isoforms in vascular diseaseCholesterol crystals identified using optical coherence tomography and virtual histology intravascular ultrasoundDeath receptors and their ligands in atherosclerosisPKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammationVascular Smooth Muscle Cells in Atherosclerosis.Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models.Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failureThe regulation of vascular smooth muscle cell apoptosis.Distinct epigenomic features in end-stage failing human heartsNew insights into atherosclerotic plaque rupture.Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence.DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndromeAgeing induced vascular smooth muscle cell senescence in atherosclerosis.DNA damage-dependent mechanisms of ageing and disease in the macro- and microvasculature.Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanismMyocardin regulates vascular smooth muscle cell inflammatory activation and diseaseApoptotic cell death in atherosclerosis.LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human AdrenalRole of apoptosis in atherosclerosis and its therapeutic implications.Poor maternal nutrition programmes a pro-atherosclerotic phenotype in ApoE-/- mice.Direct Comparison of Virtual-Histology Intravascular Ultrasound and Optical Coherence Tomography Imaging for Identification of Thin-Cap Fibroatheroma.Interleukin-1α Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2: IMPLICATIONS FOR ALLOGRAFT REJECTION.Cell death in the cardiovascular system.DNA damage and repair in atherosclerosis.Vascular smooth muscle cell senescence in atherosclerosis.The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability.Assessment of unstable atherosclerosis in mice.DNA damage, p53, apoptosis and vascular disease.Nutrient deprivation regulates DNA damage repair in cardiomyocytes via loss of the base-excision repair enzyme OGG1.Ageing and atherosclerosis: Mechanisms and therapeutic options.Expression, regulation and function of trail in atherosclerosis.Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network FormationRole of Fas/Fas-L in vascular cell apoptosis.The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.
P50
Q21183975-97000167-6B46-4DE4-8BA1-5998E3AA3B4EQ21267215-75CFF4AA-BC94-4E93-B617-3D1D3AED85CDQ24304068-FC863354-337C-49B3-BDFA-7B0BA89A9599Q26851565-89995562-715D-4374-AE0F-78C0B0FFFCF6Q27001568-35F6B056-82B7-4C88-8364-2B9406CDFAEFQ28289265-6E2E3AAB-2968-41C4-AC6E-F9C061959883Q28571334-77422A9F-F2B1-41BC-B15B-C67A0515AAE0Q28591187-C8508B36-26A9-4DDF-9091-7C9896994338Q30277316-C394B816-478A-42AF-B4B8-E86A95213A47Q30658182-6FF5DCA0-B1EB-4D37-AA14-8E6E27BA96FEQ30831517-9FE6A069-7F71-46F1-ADC6-E1C5C03A425FQ33525014-E3E79779-1E8B-4830-88DF-A6D027D94C29Q33870054-666BFB5B-9623-417D-A473-CF89D2C0D3F3Q34057105-02ACEF8E-EFA3-458C-BE5C-1451CA29BF8DQ34132067-E9DF4A58-B305-4A76-AE75-30E64A263DD4Q34286746-0B300772-8D4F-4118-A7E2-0C4F18F4249EQ34316747-D1239948-A9D2-44DD-849C-8E89E087F627Q34485057-4BEEAA04-6839-4003-AB20-162FA5E0E2D3Q34554214-8A699076-7DDC-4A70-9415-BBF7666505ADQ34985696-FBEDEECE-8A7B-4E05-BDAC-27A4BE8ED57DQ35088374-60C80492-FE5B-434B-98C2-C87E7EFE4B89Q35323782-CC9FD866-A267-4F43-AC7B-F2E0A45889BAQ35539453-A5573199-9D93-470E-BA6D-0E0C6D6D70EDQ35680832-EEC6287B-D4A7-480F-ACEF-C5DB11960E21Q35824718-BAA3C7D5-F49B-47BB-95E7-42C2F8DBBB94Q35925082-187861EC-2783-4A64-9DB7-5A80B9EC4D18Q36129679-81326A51-B2E6-4FD7-B2A0-69658B4CFEB0Q36139955-74129A8F-8ECF-4219-A49C-20AE9C85D909Q36425263-78D0B794-8252-4AA4-9E6E-F3484936D566Q36437572-C0A0BC42-6733-43F4-BB3E-0B0C72169959Q36529123-9C85900E-DA69-4357-99AA-6E2626582A42Q36678905-9C3BDD62-A0B2-4B36-B06D-A3E739E093E7Q36749103-FF3AD14E-7EE9-44C4-934D-DF01585431A9Q36768762-232C7185-2BB4-4590-8197-84AC19C31F10Q36778862-E932B681-B80F-49F9-A3C6-79E65C5C989EQ37012572-D6772E23-6024-4060-AAE2-2CB1D7C0D63DQ37025180-423CD040-5297-47FD-B050-99EF33F76F04Q37042648-B9EEF187-2F30-4C61-8CA3-79C153ED208DQ37384253-BD0F25E0-44C4-4D50-9A03-9079E52C28EEQ37591226-5B1F3A3C-FF22-4187-9A0B-11F7C4FD53FF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin R. Bennett
@ast
Martin R. Bennett
@en
Martin R. Bennett
@es
Martin R. Bennett
@nl
Martin R. Bennett
@sl
مارتن آر. بينيت
@ar
type
label
Martin R. Bennett
@ast
Martin R. Bennett
@en
Martin R. Bennett
@es
Martin R. Bennett
@nl
Martin R. Bennett
@sl
مارتن آر. بينيت
@ar
altLabel
Martin Bennett
@en
prefLabel
Martin R. Bennett
@ast
Martin R. Bennett
@en
Martin R. Bennett
@es
Martin R. Bennett
@nl
Martin R. Bennett
@sl
مارتن آر. بينيت
@ar
P106
P1153
7403467339
P21
P31
P496
0000-0002-2565-1825